Biotech Co. Sued Over Stock Drop After Bad Clinical News
An immunotherapy startup was hit with a putative shareholder class action in North Carolina federal court on Tuesday, after its stock tanked last month when its independent data advisory committee concluded...To view the full article, register now.
Already a subscriber? Click here to view full article